Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
The DOI matches its Crossref record.
Abstract
Clinical and experimental data support the concept that type I diabetes mellitus results from autoimmune destruction of pancreatic beta cells. Although both proteins and glycolipids are targets of anti-islet cell antibodies, the Ag have not been purified or characterized. Previously, we observed that rat insulinoma (RIN) cell lines varied in their reactivity with both human antibodies and murine mAb A2B5, which binds to polysialo gangliosides. To determine the chemical basis of the varied immunoreactivity, we analyzed the glycosphingolipids of 5 RIN lines. Glycolipids bound by two mAb and by antibodies in the sera of type I diabetics were identified. The more immunoreactive RIN lines contained a much higher content of gangliosides and a higher proportion of complex gangliosides. The major gangliosides were GM3, GD3, and GT3. By high performance TLC immunostaining, we demonstrated that A2B5 and R2D6, an anti-beta cell murine mAb, bound most strongly to ganglioside GT3. The binding of human sera to gangliosides was analyzed by an ELISA assay. Although both normal and diabetic sera contained antibodies to various glycolipids, binding to GT3 was significantly elevated in 31 new-onset type I diabetics (p less than 0.001). The presence of the GT3 trisialosyl epitope on human islet cells was shown by immunofluorescent staining by both R2D6 and A2B5. These findings support previous suggestions that gangliosides play an important role in the immunopathology of type I diabetes, and identify for the first time a specific ganglioside Ag that is the target for autoantibodies in a subset of diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat
Castano, L., & Eisenbarth, G. S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003243 · Cited by 644
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Emergence and significance of carbohydrate-specific antibodies
Kappler, K., & Hennet, T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0105-9 · Cited by 118
Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
Muthana, S. M., Xia, L., Campbell, C. T., Zhang, Y., & Gildersleeve, J. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119298 · Cited by 53
Natural Antibodies Against Sialoglycans
Shilova, N., Huflejt, M. E., Vuskovic, M., Obukhova, P., Navakouski, M., Khasbiullina, N., Pazynina, G., Galanina, O., Bazhenov, A., & Bovin, N. (2013) · Topics in Current Chemistry · doi:10.1007/128_2013_469 · Cited by 22
“Antibodies to ganglioside GT3 were found in patients with type 1 diabetes mellitus [16].”
Background
Metadata
- Authors
- Gillard, B. K., Thomas, J. W., Nell, L. J., & Marcus, D. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-06-01
- Volume
- 142
- Issue
- 11
- Pages
- 3826-3832
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1522361063
- Cited by
- 74
- References
- 0
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. https://app.cochat.ai/papers/10.4049/jimmunol.142.11.3826
- The paper
- Gillard, B. K., Thomas, J. W., Nell, L. J., & Marcus, D. M. (1989). Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. The Journal of Immunology. https://doi.org/10.4049/jimmunol.142.11.3826
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.